ResearcherHumboldt-Universität zu BerlinNo recent work listed
Anja Jühling
Matched on OpenAlex author ID A5070889661. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2016: 1 paper · 2017: 1 paper · 2018: 2 papers
Papers 4
- Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from cholestatic hyperbilirubinaemia-A retrospecti… Co-author DOI 10.1016/j.ejca.2018.06.001↗
- Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41416-018-0093-y↗
- Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejca.2017.06.016↗
- P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcitabine treatment. Co-author DOI 10.1016/j.prp.2016.06.001↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jana Käthe Striefler · 4 shared papers, 2016–2018 · strength 0.26
- Paper Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from chole… DOI 10.1016/j.ejca.2018.06.001↗
- Paper Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-018-0093-y↗
- Paper Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2017.06.016↗
- Marianne Sinn · 4 shared papers, 2016–2018 · strength 0.26
- Paper Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from chole… DOI 10.1016/j.ejca.2018.06.001↗
- Paper Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-018-0093-y↗
- Paper Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2017.06.016↗
- Uwe Pelzer · 4 shared papers, 2016–2018 · strength 0.26
- Paper Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from chole… DOI 10.1016/j.ejca.2018.06.001↗
- Paper Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-018-0093-y↗
- Paper Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2017.06.016↗
- Hanno B. Riess · 4 shared papers, 2016–2018 · strength 0.26
- Paper Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from chole… DOI 10.1016/j.ejca.2018.06.001↗
- Paper Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-018-0093-y↗
- Paper Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2017.06.016↗
- Marcus Bahra · 3 shared papers, 2016–2018 · strength 0.19
- Paper Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from chole… DOI 10.1016/j.ejca.2018.06.001↗
- Paper Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2017.06.016↗
- Paper P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcita… DOI 10.1016/j.prp.2016.06.001↗
- Bruno Valentin Sinn · 3 shared papers, 2016–2018 · strength 0.18
- Paper Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-018-0093-y↗
- Paper Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2017.06.016↗
- Paper P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcita… DOI 10.1016/j.prp.2016.06.001↗
- Philipp Lohneis · 3 shared papers, 2016–2018 · strength 0.18
- Paper Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-018-0093-y↗
- Paper Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2017.06.016↗
- Paper P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcita… DOI 10.1016/j.prp.2016.06.001↗
- Carsten Denkert · 3 shared papers, 2016–2018 · strength 0.18
- Paper Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-018-0093-y↗
- Paper Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2017.06.016↗
- Paper P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcita… DOI 10.1016/j.prp.2016.06.001↗
- Helmut Oettle · 3 shared papers, 2016–2018 · strength 0.18
- Paper Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-018-0093-y↗
- Paper Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejca.2017.06.016↗
- Paper P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcita… DOI 10.1016/j.prp.2016.06.001↗
- Fritz Klein · 2 shared papers, 2018 · strength 0.15
- Timm Denecke · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.